미국 PROMETHEUS AGI LLC 와 업무협약 체결

2024.03.01
AIGENDRUG signed a memorandum of understanding(MOU) with PROMETHEUS AGI LLC of the United States to commercialize artificial intelligence (AI)-based compound screening services. 

Through this contract, AIGENDRUG will develop and provide AI technology, and PROMETHEUS AGI will commercialize it and provide it to companies in the United States. 

List

Headquarter 638, 220, 1, Gwanak-ro, Gwanak-gu, Seoul, Republic of KoreaResearch Center 901, 1793, Nambusunhwan-ro, Gwanak-gu, Seoul, Republic of KoreaTel+82 70 4902 0716E-mailinfo@aigendrug.com

© AIGENDRUG CO., Ltd. ALL RIGHTS RESERVED.